Trial Profile
A phase I trial to investigate the combination of selinexor and rituximab in patients with heavily pretreated non-Hodgkin lymphomas
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 17 Oct 2014
Price :
$35
*
At a glance
- Drugs Selinexor (Primary) ; Rituximab
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions
- 17 Oct 2014 New trial record